Tylenol Levels in Bariatric Patients (NCT02982928) | Clinical Trial Compass
CompletedNot Applicable
Tylenol Levels in Bariatric Patients
United States11 participantsStarted 2017-03-06
Plain-language summary
The current study is designed to measure and evaluate the pharmacokinetic profiling of acetaminophen in the young obese patient population.
Who can participate
Age range12 Years – 21 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients older than 12, but younger than 21 years of age undergoing robotic assisted or laparoscopic bariatric surgery
* American Society of Anesthesiologists Physical Status Classification System (ASA) I, II or III
* Parent/guardian willing and able to give consent
* Patient willing to give assent, or consent
* Patients that are otherwise healthy at the discretion of the study staff
* Patients with BMI \>95th percentile
Exclusion Criteria:
* Patients with severe right heart failure or severe asthma
* Patients with deficient hepatic function that can affect drug metabolism
* Systemic steroid use within the last 3 months
* Patients who have taken acetaminophen containing medications within 24 hours of surgery date
* Patients younger than 12, but older than 21 years of age undergoing robotic assisted or laparoscopic bariatric surgery
* Patients having other procedures in addition to robotic assisted or laparoscopic bariatric surgery
* American Society of Anesthesiologists Physical Status Classification System (ASA) IV and above
* Females testing positive for pregnancy
* Parent/guardian not willing and able to give assent, or consent
* Patient not willing to give assent, or consent
* Patients with BMI \< 95th percentile